Hypertension Clinical Trials

Showing 1701-1720 of 3,009 trials

An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

NCT02537015

This study evaluated the long-term (9-months) safety of the Bimatoprost Ocular Insert in participants with Glaucoma or Ocular Hypertension who completed study FSV5-004. All the participants received Bimatoprost Ocular Insert and wore it for approximately 3 months (12 weeks), then had that Insert removed and a new Insert placed for another 26 weeks (approximately 6 months).

Primary Open-Angle GlaucomaOcular Hypertension

ForSight Vision5, Inc.81 participantsStarted Aug 2015

Fayetteville, Arkansas, United States • Artesia, California, United States • Newport Beach, California, United States +6 more locations

COMPLETEDNA

Controlling Hypertension After Severe Cerebrovascular Event

NCT02982655

The purpose of this academic lead study is to explore ideal blood pressure targets and optimum individualized anti-hypertension strategies in acute severe stroke.

Severe StrokeAcute StrokeHypertension

Xijing Hospital500 participantsStarted Jan 2017

Ankang, Shaanxi, China • Baoji, Shaanxi, China • Hanzhong, Shaanxi, China +23 more locations

An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

Controlling Hypertension After Severe Cerebrovascular Event

Related Searches

Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects

Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function

Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

A Pilot Trial of Manlikang in Reducing Salt Intake and Blood Pressure Among Patients With Hypertension

Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "

52-104 Week Off-therapy Second Extension to Study CSPP100A2365

Surveillance, Prevention and Treatment of Intra-abdominal Hypertension and Abdominal Compartment Syndrome

MK-0954E Study in Participants With Hypertension (MK-0954E-357)

Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)

WIreless Monitoring and Financial Incentives for Uncontrolled HYpertension (WIFHY) Study

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma

Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument

An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product

A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension

Heart Outcomes Prevention and Evaluation 4

DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)